FIELD: biomedicine.
SUBSTANCE: invention relates to biomedicine and can be used to determine adaptogenic activity and specific effect of certain drugs and chemical compounds on the organism of small laboratory animals. Experimentally tested animal is placed on an artificially created horizontal platform. Motion of the animal is recorded using video fixing cameras. Physical parameters are recorded with a thermal imager.
EFFECT: method enables maximum objective obtaining of data on behavior and physical state of small laboratory animals for detecting specific effect of certain drugs and chemical compounds on the body by developing experimental conditions, in which animals are subjected to forced non-reflex behavior, but excludes the effect of painful physical stimuli.
1 cl, 1 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INVESTIGATING BEHAVIOR AND PHYSICAL ENDURANCE OF EXPERIMENTAL ANIMALS | 2019 |
|
RU2699483C1 |
| METHOD OF ASSESSING INDIVIDUAL STRESS RESISTANCE OF SMALL LABORATORY ANIMALS | 2022 |
|
RU2802762C1 |
| MEANS WITH ANTISTRESS, ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITY AND COMPOSITION BASED THEREON | 2015 |
|
RU2617512C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| METHOD FOR DETECTING PSYCHOTROPIC ACTIVITY OF DRUG AND DRUG-FREE SUBSTANCES | 2012 |
|
RU2506649C1 |
| METHOD FOR NONINVASIVE TESTING OF THE DEVELOPMENT OF MODEL PATHOLOGY OF THE MUSCULOSKELETAL SYSTEM IN LABORATORY ANIMALS | 2021 |
|
RU2771256C1 |
| NEUROPROTECTIVE AGENT BASED ON BIS{2-[(2E)-4-HYDROXY-4-OXOBUT-2-ENOYLOXY]-N,N-DIETHYLETHANAMINE}BUTANDIOATE | 2015 |
|
RU2588365C1 |
| QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
| METHOD FOR SIMULATING POSTTRAUMATIC STRESS DISORDER IN ZEBRAFISH INDIVIDUALS | 2023 |
|
RU2819381C1 |
